Background 
The basic hemodynamic feature of MS is an elevation of left atrial (LA) pressure, resulting from obstruction to antegrade flow across the mitral valve. The extent of narrowing of mitral valve orifice determines the degree of elevation of LA pressure. However, a wide spectrum of LA pressures exists in patients with MS despite nearly similar mitral valve area. A linear relationship does not exist between the LA pressure and valve orifice or between LA pressure and pulmonary artery pressure. It is known that atrial and pulmonary compliances influence atrial and pulmonary hemodynamic. It is due to the complex interactions between mitral orifice area, LA compliance and pulmonary compliance that a linear relationship does not exist between mitral orifice size and LA and pulmonary artery pressures. 8 The term compliance is used to describe how easily a chamber of the heart or the lumen of a blood vessel expands when it is filled with a volume of blood. Physically, compliance (C) is defined as the change in volume (ÄV) divided by the change in pressure (ÄP) (C = ÄV / ÄP). 9 The net atrioventricular compliance (Cn) implies compliance characteristics of both the chambers atrium and ventricle, as a single unit. In case of pure mitral stenosis, left ventricular compliance is assumed to be normal. Therefore an abnormal Cn reflects abnormality of the atrial compliance. But it has been found that about one third of patients with mitral stenosis have reduced left ventricular compliance. 10 Net Cn is an important determinant of pulmonary artery pressure in mitral stenosis independently of mitral valve (MV) area and transvalvular pressure gradients. Patients with low Cn were more symptomatic with symptoms corresponding to severe increases in pulmonary artery pressures during stress echocardiography. 11 Mitral stenosis is best described as a disease continuum, with no single value that can define its severity. More specifically, a wide variation in pulmonary pressures for the same range of mitral obstruction emphasizes the need to identify key factors implicated in the development of pulmonary hypertension and functional limitation in MS. 12 The presence of pulmonary hypertension is fundamental in the clinical decision-making process for mitral stenosis (MS). 13, 14 It strongly expresses valve disease severity and conveys adverse effects on functional status, exercise tolerance, and prognosis. 15, 16 However, pulmonary pressure may not be uniquely determined by the stenotic lesion itself but by a combination of hemodynamic parameters. 17, 18 Several factors may contribute to clinical presentation and outcome in MS. Leftheart compliance plays a crucial role in the occurrence of pulmonary hypertension and symptoms. 19 Li et al 20 Nunes et al 23 showed that net atrioventricular compliance,Cn <4 mL/mm Hg best predicted unfavorable outcome in patients with mitral stenosis and Cn was found as a powerful predictor of adverse outcome, adding prognostic information beyond that provided by clinical evaluation and MV area.
In another study it was showed that Cn is an independent predictor of death in patients with significant MS who underwent percutaneous mitral valvuloplasty (PMV), even after adjustment for important prognostic factors like demographics, clinical factors (including co morbidity index), pulmonary artery pressure, ventricular function, degree of mitral regurgitation (MR), and immediate procedural results (MR severity and mitral valve area after PMV). 24 Kapoor et al 25 found that left atrial compliance significantly improved immediately after successful balloon mitral valvotomy, irrespective of the pre valvotomy left atrial pressure.
The effect of a successful PTMC on net atrioventricular compliance (Cn) is still not evaluated. The relation of post PTMC net atrioventricular compliance (Cn) and outcome parameters of PTMC has not been tested. As post PTMC atrial compliance increases, so we have hypothesized that post PTMC net atrioventricular compliance (Cn) will also be increased and it will be correlated with outcome parameters of PTMC, both clinical and echocardiographic.
Methods:
This prospective observational study was conducted in the Department of Cardiology, NICVD, from June, 2014 to May, 2015. A total of 50 patients who had had planimetered mitral valve area <1.5 cm 2 , Wilkin's score <10, isolated mitral stenosis or with not more than grade I mitral regurgitation and successful PTMC (After PTMC MVA >1.5 cm 2 or >50% increased from baseline, mean trans valvular pressure gradient <5 mm Hg or >50% reduced from baseline) were selected. Patients with concomitant pregnancy, hypertension and documented coronary artery disease were excluded. The study protocol was approved by the Ethical Review Committee of NICVD.
A complete clinical evaluation was performed on all patients the day before PTMC, immediately after PTMC and 72 hours after PTMC. Functional status was determined using the New York Heart Association (NYHA) classification based on functional capacity and dyspnea. Transthoracic echocardiography was done the day before PTMC, immediately after PTMC for procedural success and complications and 72 hours after PTMC by one expert. Patients were evaluated by 2D, Mmode and Doppler echocardiography, imaging was performed and analyzed according to the recommendations of the American Society of Echocardiography using a commercially available echocardiography (GE Vivid 5). Standard echocardiographic parameters were averaged from 3 consecutive cardiac cycles for patients in sinus rhythm or 5 consecutive cycles for patients in atrial fibrillation. Mitral valve area was measured by planimetry in parasternal short axis view. MV morphology was evaluated using the Wilkins score. Peak and mean transmitral diastolic pressure gradients were measured from Doppler profiles recorded in the apical 4-chamber view. Systolic pulmonary artery pressure (SPAP) was measured by continuous-wave Doppler tricuspid regurgitant velocity using the simplified Bernoulli equation. Left atrial diameter, left ventricular end diastolic diameter, left ventricular end systolic diameter and LV ejection fraction were measured by 2D and M mode study. Procedural complications were observed immediately after PTMC. Hemodynamic was recorded by measuring pulmonary artery systolic pressure, aortic pressure gradient, transmitral pressure gradient (peak) and LV ejection fraction. Invasive measurement of change in aortic & LA pressure after PTMC was recorded.
Assessment of Cn
Cn was determined noninvasively by means of Doppler echocardiography, Cn (mL/mm Hg) = 1270 × (planimetric MV area [cm2]/E-wave down slope [cm/s 2 ]). 21 In those patients with nonlinear diastolic flow, the mid-diastolic flow was used, which was felt to best represent the valve stenosis as opposed to early LA depressurization, and the slope was extrapolated back to obtain the initial maximal velocity.
Statistical Methods:
The data obtained from the study were analyzed and significance of differences was estimated by using statistical methods. Data was expressed as mean ± SD. The SPSS Statistical Software (17.0 version, SPSS Inc., Chicago, Illinois, USA) was used for data analysis. Continuous variables were expressed in mean & standard deviation and categorical variables as frequency and percentage. Paired Student's t-test was used to compare normally distributed continuous variables of two groups that are dependent on each other. Again two sample unpaired t-test was used to compare normally distributed continuous variables of two groups that are not dependent on each other. x 2 -test was used to compare two groups of unpaired discrete variables. To show the relationship between quantitative variables Pearson correlation test & in case of one quantitative and one ordinal variable Spearman's rank test were performed. A p-value <0.05 was considered statistically significant.
Results:
Mean age of patients of PTMC was 33.72 years (SD ± 8.71 years). Age varied from 20 to 50 years. 78 percent of the patients were female and 22 percent was male. (Fig 1) . Baseline clinical evaluation revealed that only 9 patients (18%) had history suggestive of rheumatic fever and none of them took prophylaxis against rheumatic fever. 5 patients (10%) had atrial fibrillation. 11 patients (22%) had history of left atrial spontaneous echo contrast or left atrial thrombus or previous ischemic stroke. 2 patients (4%) had history of previous mitral valve intervention (CMC or PTMC). All patients (n=50, 100%) had shortness of breath, other symptoms were palpitation (50%), chest pain, cough, orthopnoea, PND & haemoptysis (Table II) .
Baseline echocardiographic evaluation revealed most of the patient had very severe mitral stenosis (mean MVA was 0.80 ± 0.17 cm 2 , mean trans mitral peak pressure gradient was 28.83 ± 9.39 mm Hg, mean trans mitral mean pressure gradient was 16.54 ± 6.17 mm Hg) with severely elevated pulmonary artery systolic pressure (mean pulmonary artery systolic pressure was 73.28 ± 29.43mm Hg). (Table-II All patients (32 %) presented with NYHA class II heart failure improved to NYHA class I after PTMC. But those 42 % patients who presented with NYHA class IV heart failure, 14% improved to NYHA class I and 28% still remained symptomatic (22% NYHA class II and 6% NYHA class III) after PTMC. (Table-III) .
Following PTMC pulmonary arterial systolic pressure, index left atrial anteroposterior diameter, transmitral peak and mean pressure gradient, invasively measured mean left atrial pressure were significantly reduced. On the other hand, mitral valve area significantly increased after PTMC (Table IV) MVA, index left atrial anteroposterior diameter and invasively measured mean left atrial pressure had no statistically significant difference (Table VII) . NYHA class for dyspnoea showed statistically significant difference among patients with Cn >4 ml/ mm of Hg and patients with Cn <4ml/mm of Hg following PTMC (p < 0.001) ( Table VIII) .
Comparison of outcome following successful PTMC among patients with MVA < 1.5 cm 2 and patients with MVA >1.5 cm 2 revealed mitral valve area and net atrioventricular compliance had statistically significant difference but pulmonary arterial systolic pressure, transmitral peak and mean pressure gradient, index left atrial anteroposterior diameter and invasively measured mean left atrial pressure had no statistically significant difference among patients of these two groups. (Table IX ) 18.00 ± 6.78 0.247
Echocardiographic parameters following PTMC showed that mitral valve area was positively correlated to net atrioventricular compliance (Cn). Transmitral peak pressure gradient, trans mitral mean pressure gradient and pulmonary artery systolic pressure were negatively correlated to net atrioventricular compliance (Cn), Index left atrial anteroposterior diameter had no significant correlation with net atrioventricular compliance (Cn). Again invasively measured mean left atrial pressure was found negatively correlated with net atrioventricular compliance (Cn). (Table X and Fig.  -3, 4) . The pre PTMC net atrioventricular compliance was found to be positively correlated to post PTMC net atrioventricular compliance (r = 0.678, p < 0.001) (Table XI and Fig.-2) . The post Table- PTMC NYHA class for heart failure was found to be negatively correlated to post PTMC net atrioventricular compliance (r = -0.712, p < 0.001) (Table XII) .
In this study the mean age of the patients was 33.72 ± 8.71 years. From other studies of this institute, mean age of patients undergoing PTMC was found 29.7± 7.7 years by Mannan, 25 28.2±6.7 years by Kundu 27 and 28.83±9.33 years by Chowdhury. 28 So, mean age of patients of this study was a bit higher than that found from other previous studies in the same institute. A comprehensive study by Hasan-Ali et al showed mean age 30±9 years among patients undergoing PTMC. 29 Functional class status evaluation revealed 32% of study population was NYHA class II, 26% was in class III and 42% was in class IV. Mannan, 26 in his study found 5% of this study population was in NYHA class I, 63.3% was in class II, 26.7% was in class III and 5% was in class IV. Severe symptomatic patients were more in our study group. Following PTMC all patients showed improvement regarding functional class. 33 showed reduction of left atrial diameter from 4.6±0.6 to 4.3±0.7 cm after PTMC. So our study is comparable to above mentioned studies in respect of reduction of left atrial diameter after PTMC.
In this study pulmonary artery systolic pressure reduced from 73.28 ± 29.43 to 48.79 ± 21.58 mm of Hg (p<0.001). Post PTMC pulmonary artery systolic pressure, though found reduced significantly, still higher than that found in other studies. 26, 27 In this study net atrioventricular compliance increased from 3.42 ± 1.64 to 6.38 ± 7.36 ml/ mm of Hg. Aditya Kapoor et al 25 found that left atrial compliance significantly improved immediately after successful balloon mitral valvotomy, irrespective of the pre valvotomy left atrial pressure. Currently there is no available data showing the effect of a successful PTMC on net atrioventricular compliance.
In our study we found significant difference in trans mitral peak and mean pressure gradients and PASP among patients with Cn>4 ml/mm Hg & Cn <4 mi/mm Hg following successful PTMC. Again the differences in index left atrial anteroposterior diameter and invasively measured mean left atrial pressure among these two groups were not statistically significant.
Comparison of NYHA class showed significant improvement of breathlessness in the group with Cn > 4 ml/mm of Hg compared to the group with Cn <4 ml/mm of Hg. (p < 0.001).
When the above comparisons done among the patients who had mitral valve area >1.5 cm 2 following successful PTMC, then Pulmonary arterial systolic pressure, transmitral peak and mean pressure gradient, net atrioventricular compliance (Cn) and NYHA class for dyspnoea had statistically significant difference among patients with Cn >4 ml/mm of Hg and patients with Cn <4ml/mm of Hg following successful PTMC. On the other hand MVA, index left atrial anteroposterior diameter and invasively measured mean left atrial pressure had no statistically significant difference among patients of those two groups following successful PTMC. So, patients' symptoms, PASP and trans mitral gradient independently related to post PTMC net atrioventricular compliance (Cn).
In our study echocardiographic parameters with net atrioventricular compliance (Cn) following PTMC showed that transmitral peak pressure gradient, trans mitral mean pressure gradient and pulmonary artery systolic pressure were negatively correlated to net atrioventricular compliance (Cn), Index left atrial anteroposterior diameter had no significant correlation with net atrioventricular compliance (Cn) (r = -0.613, p < 0.001 and r = -0.615, p < 0.001 and r = -0.567, p < 0.001 and r = -0.334, p =0.815 respectively). Again invasively measured mean left atrial pressure was found negatively correlated with net atrioventricular compliance (Cn) (r = -0.334, p < 0.001).
The pre PTMC net atrioventricular compliance was found to be positively correlated to post PTMC net atrioventricular compliance (r = 0.678, p < 0.001). The post PTMC NYHA class for heart failure was found to be negatively correlated to post PTMC net atrioventricular compliance (r = -0.712, p < 0.001).
Study limitations
Only in hospital observations were done, no long term outcome was observed.
Conclusion
It was found from the study that successful PTMC is associated with immediate significant improvement in net atrioventricular compliance. Net atrioventricular compliance is inversely correlated with NYHA functional status, transmitral pressure gradient, pulmonary artery systolic pressure & means left atrial pressure following successful PTMC. Post PTMC net atrioventricular compliance is also positively correlated with pre PTMC net atrioventricular compliance. There is no significant correlation between net atrioventricular compliance and index left atrial anteroposterior diameter following successful PTMC.
Recommendations
Further study using large number of patients and inclusion of control group is needed to confirm our findings and to assess their utility in patients follow up and management. Long term follow up of patients following PTMC will establish the ground for prediction of long term outcome depending on post PTMC net atrioventricular compliance. Studies can be under taken to predict severity of right ventricular dysfunction & to assess patient's probability to develop left atrial thrombus depending on net atrioventricular compliance.
